A recent study in Ghana revealed that 21.1% of women referred for cancer biopsies did not ultimately receive the procedure. This significant gap highlights critical challenges within the nation's cancer care pathway, extending beyond initial awareness campaigns.
The study, which followed 243 women presenting with breast symptoms across eight hospitals in the Oti and Volta regions, uncovered multiple points of disconnection. Even when biopsy costs were covered, 53 women missed the procedure. Among the 102 women diagnosed with malignancy, 37 (36%) did not initiate treatment, pointing to both patient-related and health-system-related factors.
This situation fits into a broader narrative of healthcare access challenges in Ghana. Despite efforts to raise awareness, the journey from symptom recognition to completed treatment remains fragmented. Data shows a median time of 76 days from first presentation to treatment initiation, compared to 14 days for biopsy results. This delay often leads to advanced diagnoses, with 61% of malignancies identified at stage III or IV.
The study specifically attributed 19 cases of missed treatment to participant-related factors and 12 to health-system-related factors. It also noted that 71% of women identified fear of diagnostic and treatment costs as a barrier. Additionally, 51% reported transportation costs as a significant impediment to accessing care.
These findings underscore the need for comprehensive interventions beyond clinical care. Patient navigation, a system designed to guide individuals through complex healthcare processes, offers a potential solution. Navigators can help patients understand next steps, coordinate appointments, address financial concerns, and overcome logistical hurdles like transportation. The World Health Organisation supports patient navigation as an evidence-based intervention, particularly in fragmented healthcare systems.
Implementing effective solutions requires adapting models to Ghana's specific healthcare realities. The study's distinction between health-system-related and participant-related barriers is crucial for tailoring interventions. For instance, 22 of the 53 missed biopsies were due to system issues, while 26 were patient-related. Addressing these diverse barriers will improve patient adherence and overall cancer outcomes. Decision-makers and healthcare providers must focus on creating a seamless patient journey to ensure that awareness translates into successful treatment completion.